Baring Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Baring Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-166,774	Closed	-$18.9M	–	204
2017 Q2	$18.9M	Buy	166,774 +50,465	+43%	+$5.64M	1.23%	14
2017 Q1	$11.6M	Sell	116,309 -27,203	-19%	-$2.91M	0.81%	27
2016 Q4	$15.4M	Sell	143,512 -2,287	-2%	-$267K	1.06%	20
2016 Q3	$18.1M	Buy	145,799 +14,515	+11%	+$1.71M	1.3%	17
2016 Q2	$14M	Buy	131,284 +2,500	+2%	+$290K	1.14%	18
2016 Q1	$14.7M	Buy	128,784 +110,599	+608%	+$13M	1.23%	17
2015 Q4	$2.59M	Sell	18,185 -3,676	-17%	-$424K	0.22%	88
2015 Q3	$1.96M	Buy	+21,861	New	+$2.31M	0.18%	99

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Baring Asset Management's CBPO Position: Q3 2017 in Review

Baring Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 166,774 shares — an estimated $18.9M sold.

Baring Asset Management first reported a position in CBPO in Q3 2015 and held it in 8 quarters. The position peaked at $18.9M in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

Baring Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
Baring Asset Management sold 166,774 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $18.9M.
Baring Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 8 quarters.
Baring Asset Management's China Biologic Products Holdings, Inc. position peaked at $18.9M in Q2 2017.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.